成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Aladdin Biochemical Technology Co.,Ltd.

Firmenname:Shanghai Aladdin Biochemical Technology Co.,Ltd.
Telefon:400-6206333
E-Mail:market@aladdin-e.com
Nationalit?t:China
URL: www.aladdin-e.com/
Produkte insgesamt:48461
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

Produktkatalog

Dehydroepiandrosterone sulfate651-48-9C19H28O5S
8-Azahypoxanthine4,5-Dihydro-1H-triazolo[4,5-d]pyrimidin-4-ol2683-90-1C4H3N5O
Eculizumab (anti-Complement C5)219685-50-4
Sirukumab (anti-IL-6)1194585-53-9
Bimagrumab (anti-ACVR2B)1356922-05-8
Ulocuplumab (anti-CXCR4)1375830-34-4
Abelacimab(anti-Factor XI)2098724-83-3
Tesnatilimab (anti-NKG2D)2242758-08-1
Zansecimab (anti-ANGPT2)2415205-37-5
Meropenem-d61133424-00-6C17H25N3O5S
Ranibizumab (anti-VEGFA)347396-82-1C11H12N2O2
2-(azetidin-1-yl)ethan-1-amine795299-77-3C5H12N2
Enoblituzumab (anti-CD276)1353485-38-7
Flanvotumab (anti-TYRP1)1188277-05-5
Bermekimab (anti-IL-1a)1401965-15-8
Inebilizumab (anti-CD19)1299440-37-1
Prezalumab (anti-B7-H2)1523164-68-2
Depatuxizumab mafodotin (anti-EGFR)1585973-65-4
Tinurilimab (anti-CEACAM6)2226224-30-0
Vandortuzumab (anti-STEAP1)1557989-52-2
Galiximab (anti-CD80)357613-77-5
Ethyl 2-oxo-4-phenylbutyrateEthyl-2-oxo-4-phenylbutyrat64920-29-2C12H14O3
Pascolizumab (anti-IL-4)331243-22-2
Ocrelizumab (anti-CD20)637334-45-3C19H16N2O5
Bis(hexamethylene)triamine7-Azatridecan-1,13-diamin143-23-7C12H29N3
Ixekizumab (anti-CTLA-8)1143503-69-8
Enokizumab (anti-IL-9)909875-08-7
Concizumab (anti-TFPI)1312299-39-0
Tarextumab (anti-NOTCH3)1359940-55-8
Emibetuzumab (anti-MET)1365287-97-3
Tesidolumab (anti-Complement C5)1531594-08-7
Xentuzumab (anti-IGF1)1417158-65-6
Lacnotuzumab (anti-M-CSF)1831128-32-5
Ladiratuzumab (anti-SLC39A6)1629760-28-6
Narsoplimab (anti-MASP2)2108782-45-0
Belimumab (anti-TNFSF13B)356547-88-1
IDO-IN-132291164-02-6C26H17F3N4O
Benzyldiphenylphosphine7650-91-1C19H17P
Alizarin Yellow R sodium saltNatrium-5-[(4-nitrophenyl)azo]salicylat1718-34-9C13H8N3NaO5
Eldelumab (anti-CXCL10)946414-98-8
Tisotumab (anti-F3)1418628-81-5
Vopratelimab (anti-ICOS)2039148-04-2
Ragifilimab (anti-TNFRSF18)2207590-51-8
Daclizumab (anti-IL2RA)152923-56-3
Sonepcizumab (anti-Sphingosine-1-phosphate)1031360-18-5
Rilotumumab (anti-HGF)872514-65-3
Narnatumab (anti-RON)1188275-92-4
Carotuximab (anti-CD105)1268714-50-6
Brazikumab (anti-IL-23)1610353-18-8
Ontamalimab (anti-MADCAM1)2098790-40-8
Dostarlimab (anti-PD-1)2022215-59-2
Avdoralimab (anti-C5AR1)2226393-85-5
Datopotamab (anti-TROP2)2267989-53-5
Denintuzumab (anti-CD19)1630074-14-4
Mogamulizumab (anti-CCR4)1159266-37-1
Rosmantuzumab (anti-RSPO3)1684393-04-1
Ianalumab (anti-TNFRSF13C)1929549-92-7
Quetmolimab (anti-CX3CL1)2084037-83-0
Gemtuzumab (anti-CD33)220578-59-6
Telazorlimab (anti-TNFRSF4)2126777-87-3
Imazapic104098-48-8C14H17N3O3
Guselkumab (anti-IL-23)1350289-85-8
Labetuzumab govitecan (anti-CEACAM5)1469876-18-3
Apamistamab (anti-PTPRC)2097132-02-8
Sirtratumab (anti-SLITRK6)1824663-82-2
Nadecnemab (anti-GFRA3)2377679-19-9
Dysprosium(III) trifluoromethanesulfonate139177-62-1C3DyF9O9S3
Efalizumab (anti-ITGAL)214745-43-4
Elotuzumab (anti-SLAMF7)915296-00-3
Oxelumab (anti-TNFSF4)1186098-83-8
Seribantumab (anti-ERBB3)1334296-12-6
Zagotenemab (anti-Tau)2019133-28-7
Bexmarilimab (anti-STAB1)2259301-27-2
Lemzoparlimab (anti-CD47)2377483-71-9
Enfortumab (anti-NECTIN4)1448664-46-7
KWAR23 (anti-SIRPg)2243227-60-1
Lexatumumab (anti-TNFRSF10B)845816-02-6
Bivatuzumab (anti-CD44v6)214559-60-1
Urelumab (anti-TNFRSF9)934823-49-1
Dinutuximab (anti-GD2)1363687-32-4
Ravulizumab (anti-Complement C5)1803171-55-2
Apelin 17 TFA217082-57-0C96H156N34O20S
Lumiliximab (anti-FceR2)357613-86-6
Otilimab (anti-GM-CSF)1638332-55-4
Fulranumab (anti-NGF)902141-80-4
Vorsetuzumab (anti-CD70)1165740-62-4
Vantictumab (anti-FZD)1345009-45-1
Indusatumab (anti-GUCY2C)1497400-26-6
Tamrintamab (anti-DPEP3)2148325-59-9
Cinpanemab (anti-Alpha-synuclein)2094516-02-4
Daxdilimab (anti-ILT7)2245966-28-1
Idactamab (anti-SLC1A5)2245205-37-0
Ponsegromab (anti-GDF15)2368950-15-4
Gevokizumab (anti-IL-1b)1129435-60-4
Itolizumab (anti-CD6)1116433-11-4
Girentuximab (anti-CA9)916138-87-9
Codrituzumab (anti-GPC3)1365267-33-9
Vunakizumab (anti-IL-17a)1792181-33-9
Imaprelimab (anti-CD146)2014343-04-3
Serplulimab (anti-PDCD1)2231029-82-4
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 ? ChemicalBook. All rights reserved